Evidence map›Paper›PMID 25056967›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Transcriptional regulation of the sodium-coupled neutral amino acid transporter (SNAT2) by 17β-estradiol.

Laura A Velázquez-Villegas, Víctor Ortíz, Anders Ström, Nimbe Torres, David A Engler, Risë Matsunami, David Ordaz-Rosado, Rocío García-Becerra, Adriana M López-Barradas, Fernando Larrea and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Nutrient uptake and metabolism in osteoblasts.Current opinion in endocrine and metabolic research · 2023
    Article
  4. Article
  5. Article
  6. Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  7. Article
  8. Frontiers in pediatrics · 2019
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Laura A Velázquez-VillegasPosgrado en Ciencias Bioquímicas, Universidad Nacional Autónoma de México, 04510 México D.F., México;Departamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 14000 México D.F., México;
Víctor OrtízDepartamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 14000 México D.F., México;
Anders StrömCenter for Nuclear Receptors and Cell Signaling, University of Houston, Houston, TX 77204;
Nimbe TorresDepartamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 14000 México D.F., México;
David A EnglerProteomics Programmatic Core, Houston Methodist Hospital Research Institute, Houston, TX 77030;
Risë MatsunamiProteomics Programmatic Core, Houston Methodist Hospital Research Institute, Houston, TX 77030;
David Ordaz-RosadoDepartamento de Biología de la Reproducción, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 14000 México D.F., México; and.
Rocío García-BecerraDepartamento de Biología de la Reproducción, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 14000 México D.F., México; and.
Adriana M López-BarradasDepartamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 14000 México D.F., México;
Fernando LarreaDepartamento de Biología de la Reproducción, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 14000 México D.F., México; and.
Jan-Åke GustafssonCenter for Nuclear Receptors and Cell Signaling, University of Houston, Houston, TX 77204;Department of Biosciences and Nutrition, Karolinska Institutet, 14186 Stockholm, Sweden jgustafsson@uh.edu.
Armando R TovarDepartamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 14000 México D.F., México;
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXHouston Methodist · USKarolinska Institutet · SEMethodist Hospital · USUniversidad Nacional Autónoma de México · MXUniversity of Houston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The sodium-coupled neutral amino acid transporter 2 (SNAT2) translocates small neutral amino acids into the mammary gland to promote cell proliferation during gestation. It is known that SNAT2 expression increases during pregnancy, and in vitro studies indicate that this transporter is induced by 17β-estradiol. In this study, we elucidated the mechanism by which 17β-estradiol regulates the transcription of SNAT2. In silico analysis revealed the presence of a potential estrogen response element (ERE) in the SNAT2 promoter. Reporter assays showed an increase in SNAT2 promoter activity when cotransfected with estrogen receptor alpha (ER-α) after 17β-estradiol stimulation. Deletion of the ERE reduced estradiol-induced promoter activity by 63%. Additionally, EMSAs and supershift assays showed that ER-α binds to the SNAT2 ERE and that this binding competes with the interaction of ER-α with its consensus ERE. An in vivo ChIP assay demonstrated that the binding of ER-α to the SNAT2 promoter gradually increased in the mammary gland during gestation and that maximal binding occurred at the highest 17β-estradiol serum concentration. Liquid chromatography-elevated energy mass spectrometry and Western blot analysis revealed that the SNAT2 ER-α-ERE complex contained poly(ADP-ribose) polymerase 1, Lupus Ku autoantigen protein p70, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) proteins and that the silencing of each of these proteins nearly abolished 17β-estradiol-stimulated SNAT2 promoter activity. Nuclear levels of GAPDH increased progressively during gestation in the mammary gland, and GAPDH binding was nucleotide-specific for the SNAT2 ERE. Thus, this study provides new insights into how the mammary epithelium adapts to control amino acid uptake through the transcriptional regulation of the SNAT2 transporter via 17β-estradiol.

Indexed as

Amino Acid Transport System AAmino Acid Transport SystemsAnimalsAntigens, NuclearBase SequenceCell NucleusDNA-Binding ProteinsEpitheliumEstradiolEstrogen Receptor alphaFemaleGene Expression RegulationGlyceraldehyde-3-Phosphate DehydrogenasesHeLa CellsHumansKu AutoantigenAmino Acid Transport System AAmino Acid Transport SystemsAntigens, NuclearDNA-Binding ProteinsEstradiolEstrogen Receptor alphaglyceraldehyde 3-phosphate dehydrogenase (304-313)Glyceraldehyde-3-Phosphate DehydrogenasesKu AutoantigenPeptide FragmentsPoly(ADP-ribose) PolymerasesSlc38a2 protein, ratXrcc6 protein, humanXrcc6 protein, ratamino acid transportcoactivator

Identifiers

PMID25056967
PMCPMC4128162
OpenAlexW2092684700

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.